Review
Open access
Aug 2026
Exploring factors impacting quality of life in breast cancer patients undergoing adjuvant hormone therapy: insights from a cohort in northeastern Morocco
Purpose: Considering that the recommended duration of adjuvant hormone therapy in localised breast cancer is at least 5 years, it becomes crucial to investigate the quality of life (QOL) of these patients and the factors influencing it. Objectives: To assess the QOL and identify factors impacting it in patients with lo...
Hafssa El Hilali, Nassiba Bahra, Sanae Guennouni et al.
· ecancermedicalscience · 0 citations